We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

BioAlliance Announces Positive Preliminary Pivotal Phase III Results in Herpes Labialis with Acyclovir Lauriad®

News   Aug 27, 2009

 
BioAlliance Announces Positive Preliminary Pivotal Phase III Results in Herpes Labialis with Acyclovir Lauriad®
 
 
 

RELATED ARTICLES

Tech Behind Bitcoin Could Improve Medications of the Future

News

Researchers have developed a prototype of an app that may potentially prescribe the optimal dose of medicine for the individual patient, as well as prevent counterfeit products.

READ MORE

Pomegranate Juice During Pregnancy May Improve Brain Development

News

Clinical researchers are exploring whether pomegranate juice intake during pregnancy can have a protective effect. Now, researchers present their preliminary findings from a clinical trial of expectant mothers whose babies were diagnosed with intrauterine growth restriction (IUGR).

READ MORE

Lab-on-a-Chip Aids Search for Drugs to Prevent Blood Clots

News

A tiny lab the size of a postage stamp could be the next "big thing" in the search for safer anti-clotting drugs to prevent heart attacks and strokes.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE